advertisement
Usui Y 17
Showing records 1 to 17 |
Display all abstracts from Usui Y98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisNamba K; Namba K
Japanese Journal of Ophthalmology 2022; 66: 130-141
97972 Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 PatientsKunimi K; Usui Y
Ocular Immunology and Inflammation 2022; 30: 223-230
98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisTakase H
Japanese Journal of Ophthalmology 2022; 66: 130-141
97972 Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 PatientsAsakage M
Ocular Immunology and Inflammation 2022; 30: 223-230
98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisUsui Y
Japanese Journal of Ophthalmology 2022; 66: 130-141
97972 Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 PatientsMaehara C
Ocular Immunology and Inflammation 2022; 30: 223-230
98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisNitta F
Japanese Journal of Ophthalmology 2022; 66: 130-141
97972 Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 PatientsTsubota K
Ocular Immunology and Inflammation 2022; 30: 223-230
98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisMaruyama K; Kusuhara S
Japanese Journal of Ophthalmology 2022; 66: 130-141
97972 Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 PatientsMitsuhashi R
Ocular Immunology and Inflammation 2022; 30: 223-230
98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisTakeuchi M
Japanese Journal of Ophthalmology 2022; 66: 130-141
97972 Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 PatientsUmazume A
Ocular Immunology and Inflammation 2022; 30: 223-230
98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisAzumi A
Japanese Journal of Ophthalmology 2022; 66: 130-141
97972 Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 PatientsKezuka T; Sakai JI
Ocular Immunology and Inflammation 2022; 30: 223-230
98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisYanai R; Kaneko Y
Japanese Journal of Ophthalmology 2022; 66: 130-141
97972 Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 PatientsGoto H
Ocular Immunology and Inflammation 2022; 30: 223-230
98571 Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosisHasegawa E; Nakai K; Tsuruga H; Morita K; Kaburaki T
Japanese Journal of Ophthalmology 2022; 66: 130-141